Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The purpose of this study is to continue to assess the safety of certolizumab pegol in combination with methotrexate (MTX).
Epistemonikos ID: 48a7b7b440cdefc73ce89daa46bd832ed7108f87
First added on: May 05, 2024